Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308)

G. Curigliano; H. J. Burstein; E. P. Winer; M. Gnant; P. Dubsky; S. Loibl; M. Colleoni; M. M. Regan; M. Piccart-Gebhart; H. J. Senn; B. Thürlimann; F. André; J. Baselga; J. Bergh; H. Bonnefoi; S. Y. Brucker; F. Cardoso; L. Carey; E. Ciruelos; J. Cuzick; C. Denkert; A. Di Leo; B. Ejlertsen; P. Francis; V. Galimberti; J. Garber; B. Gulluoglu; P. Goodwin; N. Harbeck; D. F. Hayes; C. S. Huang; J. Huober; H. Khaled; J. Jassem; Z. Jiang; P. Karlsson; M. Morrow; R. Orecchia; K. C. Osborne; O. Pagani; A. H. Partridge; K. Pritchard; J. Ro; E. J.T. Rutgers; F. Sedlmayer; V. Semiglazov; Z. Shao; I. Smith; M. Toi; A. Tutt; G. Viale; T. Watanabe; T. J. Whelan; B. Xu

doi:10.1093/annonc/mdy537

Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308)

G. Curigliano
, H. J. Burstein
, E. P. Winer
, M. Gnant
, P. Dubsky
, S. Loibl
, M. Colleoni
, M. M. Regan
, M. Piccart-Gebhart
, H. J. Senn
, B. Thürlimann
, F. André
, J. Baselga
, J. Bergh
, H. Bonnefoi
, S. Y. Brucker
, F. Cardoso
, L. Carey
, E. Ciruelos
, J. Cuzick

C. Denkert, A. Di Leo, B. Ejlertsen, P. Francis, V. Galimberti, J. Garber, B. Gulluoglu, P. Goodwin, N. Harbeck, D. F. Hayes, C. S. Huang, J. Huober, H. Khaled, J. Jassem, Z. Jiang, P. Karlsson, M. Morrow, R. Orecchia, K. C. Osborne, O. Pagani, A. H. Partridge, K. Pritchard, J. Ro, E. J.T. Rutgers, F. Sedlmayer, V. Semiglazov, Z. Shao, I. Smith, M. Toi, A. Tutt, G. Viale, T. Watanabe, T. J. Whelan, B. Xu

医学部

科研成果: 期刊稿件 › 评论/辩论

75 引用（Scopus）

摘要

In the original article, the disclosure was incomplete. This has now been updated to add the statement for J. Baselga: JBa is on the Board of Directors for Varian Medical Systems, Bristol-Myers Squibb, and is a past board member of Grail. He has performed consulting and/or advisory work for Roche, Lilly, and Novartis. Also, originally the disclosure was part of the Supplementary Material, but this has now been moved to the article. The funding statement has also been updated as follows: JBa was founded by the NIH grant P30CA008748.

源语言	英语
文章编号	mdy537
页（从-至）	1181
页数	1
期刊	Annals of Oncology
卷	30
期	7
DOI	https://doi.org/10.1093/annonc/mdy537
出版状态	已出版 - 1 7月 2019

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

可持续发展目标 3 良好健康与福祉

访问文件

10.1093/annonc/mdy537

其它文件与链接

链接到 Scopus 的出版物

学术指纹

探究 'Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308)' 的科研主题。它们共同构成独一无二的学术指纹。

引用此

Curigliano, G., Burstein, H. J., Winer, E. P., Gnant, M., Dubsky, P., Loibl, S., Colleoni, M., Regan, M. M., Piccart-Gebhart, M., Senn, H. J., Thürlimann, B., André, F., Baselga, J., Bergh, J., Bonnefoi, H., Brucker, S. Y., Cardoso, F., Carey, L., Ciruelos, E., ... Xu, B. (2019). Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308). Annals of Oncology, 30(7), 1181. 文章 mdy537. https://doi.org/10.1093/annonc/mdy537

Curigliano, G. ; Burstein, H. J. ; Winer, E. P. 等. / Corrigendum : De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308). 在: Annals of Oncology. 2019 ; 卷 30, 号码 7. 页码 1181.

@article{95a234f1782640b6b917ad5364426bab,

title = "Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308)",

abstract = "In the original article, the disclosure was incomplete. This has now been updated to add the statement for J. Baselga: JBa is on the Board of Directors for Varian Medical Systems, Bristol-Myers Squibb, and is a past board member of Grail. He has performed consulting and/or advisory work for Roche, Lilly, and Novartis. Also, originally the disclosure was part of the Supplementary Material, but this has now been moved to the article. The funding statement has also been updated as follows: JBa was founded by the NIH grant P30CA008748.",

author = "G. Curigliano and Burstein, \{H. J.\} and Winer, \{E. P.\} and M. Gnant and P. Dubsky and S. Loibl and M. Colleoni and Regan, \{M. M.\} and M. Piccart-Gebhart and Senn, \{H. J.\} and B. Th{\"u}rlimann and F. Andr{\'e} and J. Baselga and J. Bergh and H. Bonnefoi and Brucker, \{S. Y.\} and F. Cardoso and L. Carey and E. Ciruelos and J. Cuzick and C. Denkert and \{Di Leo\}, A. and B. Ejlertsen and P. Francis and V. Galimberti and J. Garber and B. Gulluoglu and P. Goodwin and N. Harbeck and Hayes, \{D. F.\} and Huang, \{C. S.\} and J. Huober and H. Khaled and J. Jassem and Z. Jiang and P. Karlsson and M. Morrow and R. Orecchia and Osborne, \{K. C.\} and O. Pagani and Partridge, \{A. H.\} and K. Pritchard and J. Ro and Rutgers, \{E. J.T.\} and F. Sedlmayer and V. Semiglazov and Z. Shao and I. Smith and M. Toi and A. Tutt and G. Viale and T. Watanabe and Whelan, \{T. J.\} and B. Xu",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2019.",

year = "2019",

month = jul,

day = "1",

doi = "10.1093/annonc/mdy537",

language = "英语",

volume = "30",

pages = "1181",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

number = "7",

}

Curigliano, G, Burstein, HJ, Winer, EP, Gnant, M, Dubsky, P, Loibl, S, Colleoni, M, Regan, MM, Piccart-Gebhart, M, Senn, HJ, Thürlimann, B, André, F, Baselga, J, Bergh, J, Bonnefoi, H, Brucker, SY, Cardoso, F, Carey, L, Ciruelos, E, Cuzick, J, Denkert, C, Di Leo, A, Ejlertsen, B, Francis, P, Galimberti, V, Garber, J, Gulluoglu, B, Goodwin, P, Harbeck, N, Hayes, DF, Huang, CS, Huober, J, Khaled, H, Jassem, J, Jiang, Z, Karlsson, P, Morrow, M, Orecchia, R, Osborne, KC, Pagani, O, Partridge, AH, Pritchard, K, Ro, J, Rutgers, EJT, Sedlmayer, F, Semiglazov, V, Shao, Z, Smith, I, Toi, M, Tutt, A, Viale, G, Watanabe, T, Whelan, TJ & Xu, B 2019, 'Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308)', Annals of Oncology, 卷 30, 号码 7, mdy537, 页码 1181. https://doi.org/10.1093/annonc/mdy537

Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308). / Curigliano, G.; Burstein, H. J.; Winer, E. P. 等.
在: Annals of Oncology, 卷 30, 号码 7, mdy537, 01.07.2019, 页码 1181.

科研成果: 期刊稿件 › 评论/辩论

TY - JOUR

T1 - Corrigendum

T2 - De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308)

AU - Curigliano, G.

AU - Burstein, H. J.

AU - Winer, E. P.

AU - Gnant, M.

AU - Dubsky, P.

AU - Loibl, S.

AU - Colleoni, M.

AU - Regan, M. M.

AU - Piccart-Gebhart, M.

AU - Senn, H. J.

AU - Thürlimann, B.

AU - André, F.

AU - Baselga, J.

AU - Bergh, J.

AU - Bonnefoi, H.

AU - Brucker, S. Y.

AU - Cardoso, F.

AU - Carey, L.

AU - Ciruelos, E.

AU - Cuzick, J.

AU - Denkert, C.

AU - Di Leo, A.

AU - Ejlertsen, B.

AU - Francis, P.

AU - Galimberti, V.

AU - Garber, J.

AU - Gulluoglu, B.

AU - Goodwin, P.

AU - Harbeck, N.

AU - Hayes, D. F.

AU - Huang, C. S.

AU - Huober, J.

AU - Khaled, H.

AU - Jassem, J.

AU - Jiang, Z.

AU - Karlsson, P.

AU - Morrow, M.

AU - Orecchia, R.

AU - Osborne, K. C.

AU - Pagani, O.

AU - Partridge, A. H.

AU - Pritchard, K.

AU - Ro, J.

AU - Rutgers, E. J.T.

AU - Sedlmayer, F.

AU - Semiglazov, V.

AU - Shao, Z.

AU - Smith, I.

AU - Toi, M.

AU - Tutt, A.

AU - Viale, G.

AU - Watanabe, T.

AU - Whelan, T. J.

AU - Xu, B.

PY - 2019/7/1

Y1 - 2019/7/1

N2 - In the original article, the disclosure was incomplete. This has now been updated to add the statement for J. Baselga: JBa is on the Board of Directors for Varian Medical Systems, Bristol-Myers Squibb, and is a past board member of Grail. He has performed consulting and/or advisory work for Roche, Lilly, and Novartis. Also, originally the disclosure was part of the Supplementary Material, but this has now been moved to the article. The funding statement has also been updated as follows: JBa was founded by the NIH grant P30CA008748.

AB - In the original article, the disclosure was incomplete. This has now been updated to add the statement for J. Baselga: JBa is on the Board of Directors for Varian Medical Systems, Bristol-Myers Squibb, and is a past board member of Grail. He has performed consulting and/or advisory work for Roche, Lilly, and Novartis. Also, originally the disclosure was part of the Supplementary Material, but this has now been moved to the article. The funding statement has also been updated as follows: JBa was founded by the NIH grant P30CA008748.

UR - https://www.scopus.com/pages/publications/85071164178

U2 - 10.1093/annonc/mdy537

DO - 10.1093/annonc/mdy537

M3 - 评论/辩论

C2 - 30624592

AN - SCOPUS:85071164178

SN - 0923-7534

VL - 30

SP - 1181

JO - Annals of Oncology

JF - Annals of Oncology

IS - 7

M1 - mdy537

ER -

Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S 等. Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308). Annals of Oncology. 2019 7月 1;30(7):1181. mdy537. doi: 10.1093/annonc/mdy537